Pupm&Dump trading strategy idea. $LPCN is rising too much today. The demand for shares of the company looks lower than the supply. This and other conditions can cause a fall in the share price today. So I opened a short position from $1,54; stop-loss — $1,6; take-profit — $1,42/MOC Do not view this idea as a recommendation for trading or investing. It is...
Weekly Chart In Uptrend, sideway, near support OBV > OBV40 ( in my OBV script, weekly chart uses 40 week) Entry 1.3 Stop 1 Target 2.3 Risk management is much more important than a good entry point. The max Risk of each plan should be less than 1% of an account. I am not a PRO trader. I trade option to test my trading plan with small cost.
Just a trading setup I'm monitoring on my watchlist no firm price target as of yet. There is cup with handle pattern that has been forming for months here. After forming the cup and getting rejected at 2.50 USD The stock has been trending down slowly and consolidating in a channel. A break of this channel could prove to be a nice swing trade opportunity.
No investment advice! I do this only for practicing. I see a cup and handle Very nice risk / reward here. Upcoming Catalysts: LPCN 1144 Non-alcoholic fatty liver disease (NAFLD) / Non-alcoholic steatohepatitis (NASH) Phase 2 Mid-2021 Phase 2 top-line change in liver fat data met primary endpoint January 12, 2021. 36-week biopsy data are expected mid-2021.
Price seems to have a lot of support around 1.80 , which looks like a nice point to enter. I would wait and see what this week holds, as I suspect it could go test that support again. I see this stock as a long-term play, but the price might oscillate around that support once more before rising. I will pay attention to the MA90 crossover, as it could indicate a...
First i want to give a shout out to my research department for sliding this across my virtual desk. Jeff you the MAN . 1 in 400 adult in the USA has some form of Cirrhosis 1 in 400 Boomer has that shit . Comes in LPCN with a patented treatment of that deadly condition. Wait they are going to court for that patent Insiders are telling me the case is a slam dunk ...
LPCN : So what are your thoughts? Does it qualify for a cup and handle ? Definitely not your typical cup, right? But I do smell coffee here. No cup no coffee. The pattern is confirmed once we break the previous higher high (the top of the cup). I'm already in the trade. Price target on the chart. Trade safe.
price pullback to 1.77 , wait confirmation and strong BUY to 15
NASDAQ:LPCN Possible Scenario: LONG Evidence: Price Action This is my idea and could be wrong 100% * It's a good buy opportunity right now, and it's ready to fly soon.
BREAKOUT STOCK ALERT UPDATE $LPCN - Lipocine Inc. - Common Stock Initial Alert Price: $1.42 Price High: $2.54 % Gains/Losses: 78.87% (+59% More Than Expected) Potential Stop Loss: $2.413 LPCN hit $2.54 in yesterday's pre-market session providing a 78.87% Gain on our initial alert on Dec. 22nd. The stock pulled back to the $2.20 Price Levels and found strong...
Came across this stock at r/pennystocks. Before buying, wait for it to break the resistance line and the 200 weekly MA.
i like these multiple higher lows. very ascending wedge -ish. looks like that local high its having trouble with. failed to break it twice, but still, higher lows. now about to test the 3rd time?! i see it breaking. divergence on the daily macd. first target - local high, but shortly after that is the gap fill...if it keeps up a 3rd target could be next local highs
I know bears will say they do not have much money to survive to last 6 month and need to dilute shares. Bulls will uphold Zacks research target to $10. Am just trying to make sense of technical picture. So we have a rising 200 ma supporting the rise with 10ema, 20ma and 50ma creating a grinding action. I am in at a very cheap price. Currently up 133%. Breakout...
Looks like an ascending wedge for LPCN coming up to FDA approval.
Contextual immersion trading strategy idea. Lipocine Inc., a clinical-stage biopharmaceutical company, focuses on the development of pharmaceutical products for the treatment of metabolic and endocrine disorders. The demand for shares of the company looks higher than the supply. This and other conditions can cause a rise in the share price in the next days. So...